Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common stock, par value $0.00001 per share
-
Shares outstanding
-
52,942,731
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
31,212,908
-
Shares change
-
+31,212,908
-
Total reported value, excl. options
-
$1,098,804,001
-
Value change
-
+$1,098,804,001
-
Number of buys
-
51
-
Price
-
$35.50
Significant Holders of PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share (PMVP) as of Q3 2020
51 filings reported holding PMVP - PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share as of Q3 2020.
PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share (PMVP) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31,212,908 shares
of 52,942,731 outstanding shares and own 59% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (7,330,423 shares), INTERWEST VENTURE MANAGEMENT CO (6,469,911 shares), VIKING GLOBAL INVESTORS LP (2,641,840 shares), BOXER CAPITAL, LLC (2,268,236 shares), Avoro Capital Advisors LLC (1,850,000 shares), RA CAPITAL MANAGEMENT, L.P. (1,710,265 shares), WELLINGTON MANAGEMENT GROUP LLP (1,645,822 shares), PERCEPTIVE ADVISORS LLC (605,556 shares), VICTORY CAPITAL MANAGEMENT INC (557,843 shares), and BlackRock Inc. (542,038 shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.